Found 6 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
UCLA Department of Medicine, Division of Hematology/Oncology
Learn More & Join Trial
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec PHASE2 1.0 OBJECTIVES 1.1 To test the activity of arsenic trioxide in combination ...
Show More Location
University of New Mexico
Learn More & Join Trial
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, work in di...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) PHASE1 In this research study, the investigators are looking to see whether the co...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial